Prostate cancer screening cuts death risk by 13% in major European study

Getty Images/jamesbenet

By Ella Pickover, PA Media

Prostate cancer screening can reduce deaths by 13%, found a large European study across two decades.

The research suggests screening has a “more favourable harm-to-benefit profile than previously estimated”, although experts acknowledge the well-known harms of overdiagnosis and overtreatment remain a “critical concern”.